Mon. 3 Jun 2024, 11:51am ET
Benzinga
Biotech, News, FDA, General
ChromaDex Gets Orphan Designation Status From FDA For Nicotinamide Riboside Chloride For Treatment Of Ataxia Telangiectasia
Company Profile